Intest Res Search

CLOSE


Published online August 2, 2019.
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
This issue chosen by the Editor of Intestinal Research is “Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study” performed by Park S-K, et al.

5-aminosalicylic acid (5-ASA) is currently established as a standard treatment for first-line treatment of mild-to-moderate UC. This study have reported treatment adherence, patients’ satisfaction and treatment efficacy of once daily (OD) and divided daily (DD) dosing in the Korean ulcerative colitis (UC) patients.

In this study, 180 patients were randomly assigned to the OD or DD group in a 1:1 ratio. The adherence rates were not different between the OD group and DD group. The patients’ satisfaction of the OD group was higher than that of the DD group. At 1 year, 5-ASA OD dosing might have the same effect as DD for the maintenance of UC remission (91.2% and 95.5%, respectively).

Read more about the adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis.

In addition to this article, read other related articles listed below about 5-ASA maintain treatment and other therapeutic options for UC.

Best regards,
Related article
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next